Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report

被引：0
|
作者：
Ahluwalia, Manmeet Singh
Ozair, Ahmad
Khosla, Atulya Aman
Patel, Neha
Elson, Paul
Murphy, Erin Sennett
Yu, Jennifer S.
Chao, Samuel T.
Suh, John H.
Stevens, Glen
Peereboom, David M.
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin Fdn, Solon, OH USA
[4] Cleveland Clin, Brunswick Urgent Care, Cleveland, OH USA
[5] Case Western Reserve Univ, Dept Radiat Oncol, Rose Ella Burkhart Brain Tumor & Neuro Oncol Ctr, Cleveland Clin,Lerner Coll Med, Cleveland, OH USA
[6] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH USA
[7] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PHASE I STUDY OF RUXOLITINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS AND GLIOBLASTOMA
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Yu, Jennifer
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 51 - 51
  • [22] Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: Phase II clinical trial
    Lanzetta, G
    Campanella, C
    Rozzi, A
    Nappa, M
    Costa, A
    Fedele, F
    Innocenzi, G
    Gagliardi, FM
    Salvati, M
    Minniti, G
    Frati, A
    Frati, L
    Vecchione, A
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5159 - 5164
  • [23] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [24] A PHASE I TRIAL OF PEMBROLIZUMAB AND VORINOSTAT COMBINED WITH TEMOZOLOMIDE AND RADIATION THERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA (NCT03426891)
    Sahebjam, Solmaz
    Forsyth, Peter
    Nam Tran
    Mokhtari, Sepideh
    Arrington, John
    Jaglal, Michael
    Etame, Arnold
    Liu, James
    Wicklund, Melissa
    Gatewood, Tyra
    Macaulay, Robert
    Robinson, Timothy
    Yu, Michael
    NEURO-ONCOLOGY, 2018, 20 : 2 - 2
  • [25] Phase I trial of vatalanib (PTK787) in combination with standard radiation and temozolomide in patients with newly diagnosed glioblastoma
    Batchelor, T.
    Eichler, A. F.
    Plotkin, S. R.
    Drappatz, J.
    Wen, P.
    Sorensen, A. G.
    Gerstner, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE
    Loughan, Ashlee
    Shafer, Danielle
    Lanoye, Autumn
    Braun, Sarah
    Dent, Paul
    Malkin, Mark
    NEURO-ONCOLOGY, 2017, 19 : 141 - 142
  • [27] First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma
    Allen, Bryan G.
    Bodeker, Kellie L.
    Smith, Mark C.
    Monga, Varun
    Sandhu, Sonia
    Hohl, Raymond
    Carlisle, Thomas
    Brown, Heather
    Hollenbeck, Nancy
    Vollstedt, Sandy
    Greenlee, Jeremy D.
    Howard, Matthew A.
    Mapuskar, Kranti A.
    Seyedin, Steven N.
    Caster, Joseph M.
    Jones, Karra A.
    Cullen, Joseph J.
    Berg, Daniel
    Wagner, Brett A.
    Buettner, Garry R.
    TenNapel, Mindi J.
    Smith, Brian J.
    Spitz, Douglas R.
    Buatti, John M.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6590 - 6597
  • [28] Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Coan, A. D.
    Bailey, L.
    Janney, D.
    Lu, C.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
    Chang, SM
    Lamborn, KR
    Malec, M
    Larson, D
    Wara, W
    Sneed, P
    Rabbitt, J
    Page, M
    Nicholas, MK
    Prados, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 353 - 357
  • [30] Phase I study of ruxolitinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and glioblastoma.
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John H.
    Chao, Samuel T.
    Murphy, Erin Sennett
    Yu, Jennifer S.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    Wei, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345